RecallGuardianCanada
Drugs· Updated September 27, 2024

M-Eslon (morphine sulfate) ER capsules: One lot recalled as some bottles labelled as M-Eslon 30 mg may contain 60 mg capsules, which may pose an overdose risk

Critical priority
Recalled product: M-Eslon (morphine sulfate) ER capsules: One lot recalled as some bottles labelled as M-Eslon 30 mg may contain 60 mg capsules, which may pose an overdose risk
What you should do
  1. 1Check your M-Eslon (morphine sulfate) medication bottle or package.
  2. 2If your prescription is for 30 mg, the capsules should be pink and clear.
  3. 3If it contains 60 mg capsules (orange and clear), or if you are unsure, do not take these capsules and contact your pharmacy immediately.
  4. 4Your pharmacist will check the capsules and provide you with a replacement if needed.
  5. 5Return the affected product to your pharmacy for proper disposal.
The issue

Product safety

Affected product

M-Eslon (morphine sulfate) bottles labelled to contain 30 mg extended-release capsules may contain 60 mg extended-release capsules

Where it was sold

Canada (national)Reported in the official notice — confirm there.

Issued by

Health Canada

Read the official Government of Canada notice

RecallGuardian ranks, illustrates and rewrites recalls in plain language. The official notice is authoritative — confirm model numbers, lot codes, dates and remedies there.

All recalls
M-Eslon (morphine sulfate) ER capsules: One lot recalled as some bottles labelled as M-Eslon 30 mg may contain 60 mg capsules, which may pose an overdose risk — recall · RecallGuardian